News

The mobile units address critical access barriers by bringing FDA-approved targeted therapy directly to local clinics and communities through equipped RVs.
The US biosimilar market expands with new denosumab options, enhancing treatment for patients with osteoporosis and ...
Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...
The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...
The FDA has authorized CLAIRITY BREAST, the first AI tool to predict a woman’s 5-year breast cancer risk using routine ...
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...
I think the commission and the staff are more encouraged than we have been any time in the past to date.” By Alander Rocha, ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
ProKidney shares surged 500% on positive Phase 2 CKD results. Read why I remain cautious about PROK stock despite the recent ...
The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...
The ruling reverses the judge’s own decision from two years ago that allowed Washington state and 17 other states to continue ...